Notably, CML LSCs express higher levels of IL-1 receptors (IL-1Rs) and are more sensitive to IL-1-induced NF-κB signaling than normal HSCs. The gene discussed is NFKB1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.